Attached files
file | filename |
---|---|
S-1 - S-1 - Aclaris Therapeutics, Inc. | a2225650zs-1.htm |
EX-3.4 - EX-3.4 - Aclaris Therapeutics, Inc. | a2225650zex-3_4.htm |
EX-3.1 - EX-3.1 - Aclaris Therapeutics, Inc. | a2225650zex-3_1.htm |
EX-10.4 - EX-10.4 - Aclaris Therapeutics, Inc. | a2225650zex-10_4.htm |
EX-10.5 - EX-10.5 - Aclaris Therapeutics, Inc. | a2225650zex-10_5.htm |
EX-10.8 - EX-10.8 - Aclaris Therapeutics, Inc. | a2225650zex-10_8.htm |
EX-10.12 - EX-10.12 - Aclaris Therapeutics, Inc. | a2225650zex-10_12.htm |
EX-10.2 - EX-10.2 - Aclaris Therapeutics, Inc. | a2225650zex-10_2.htm |
EX-10.7 - EX-10.7 - Aclaris Therapeutics, Inc. | a2225650zex-10_7.htm |
EX-10.6 - EX-10.6 - Aclaris Therapeutics, Inc. | a2225650zex-10_6.htm |
EX-23.1 - EX-23.1 - Aclaris Therapeutics, Inc. | a2225650zex-23_1.htm |
EX-10.3 - EX-10.3 - Aclaris Therapeutics, Inc. | a2225650zex-10_3.htm |
EX-10.1 - EX-10.1 - Aclaris Therapeutics, Inc. | a2225650zex-10_1.htm |
Exhibit 21.1
Subsidiaries of Aclaris Therapeutics, Inc.
Name of Subsidiary |
|
Jurisdiction of Incorporation or |
|
|
|
Aclaris Therapeutics International, Ltd. |
|
United Kingdom |